Cancer Drugs Market (Cytotoxic, Targeted) is projected to reach US$ 30 Billion by 2024

Share this news:

ReportsnReports.com adds “China Cancer Drugs Market, by Drugs (Cytotoxic, Targeted, etc.), Cancer Types(Lung, Stomach, Breast, etc.), by Therapy & Companies” report to its research store.

Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health burden in both developed and developing countries.

By Drugs

Cytotoxic Drugs: Antimetabolities, Plant Alkaloids, Alkylating Agents, Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs & Traditional Chinese Medicine (TCM)

By Cancer: Lung Cancer, Stomach Cancer, Breast Cancer, Esophageal Cancer & Liver Cancer

By Therapy: Chemotherapy, Targeted Therapy, Hormonal Therapy

Place a direct purchase order on this China Cancer Drugs Market report at USD 1990 (Single User License) https://www.reportsnreports.com/purchase.aspx?name=1606562.

Companies Covered in the Cancer Drugs Market Report:
1. Merck
2. Celegene
3. Eli Lilly
4. Roche
5. Sino BioPharma

The rate of cancer incidences in China is exploding very rapidly; nearly 4 million people diagnosed and almost 3 million died from it. For instance; due to increasing air pollution over the last couple of years, lung cancer has increased 50% in Beijing only. Anticancer drugs act like an inhibitor that prevents cancer cells to grow.

In addition; factors like growing awareness regarding cancer diagnosis & treatment, advancement in cancer drugs and therapies, rise in cancer awareness programs like breast cancer screening, investment in healthcare infrastructure are expected to drive China anti-cancer drugs market positively over the forecast period. However, major side-effects of cancer drugs and its high cost are certainly restraining the China anti-cancer drugs market to reach its full potential.

The Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

Complete report on China Cancer Drugs Market spread across 102 pages providing 5 company profiles available at https://www.reportsnreports.com/reports/1606562-china-cancer-drugs-market-by-drugs-cytotoxic-targeted-etc-cancer-typeslung-stomach-breast-etc-by-therapy-companies.html.

By Drugs – Cytotoxic Drugs leads the Cancer Drugs Market in China: Based on the drugs type, China cancer drugs market is segmented into cytotoxic drugs, targeted drugs, Monoclonal Antibiotics, hormonal drugs, TCM and Others. The cytotoxic drugs segment is further classified into Antimetabolites, Plant Alkaloids and Alkylating Agents.

By Cancer – Lungs Cancer accounts for the largest share of China Cancer Drugs Market: On the basis of cancer type, China cancer drugs market is segmented into Lung, Stomach, Breast, Esophageal, Liver & Others. Lung, Breast and Stomach Cancer dominates the China anti-cancer drugs market and is expected to do so in the near future.

By Therapy – Targeted Therapy is expected to grow significantly during the forecast period: By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market.

Inquire for a discount at https://www.reportsnreports.com/contacts/discount.aspx?name=1606562.

Company Analysis:

Some of the prominent companies competing in the China Anti-Cancer Drugs Market, and profiled in the report include Merck, Celegene, Eli Lilly, Roche and Sino BioPharma.

Client can purchase this report in sections through Purchase by Chapter Tab given above

This market research report provides a complete analysis of the China Cancer Drugs Market, Growth Drivers, Challenges, and their projections for the upcoming years.

Table of Contents:
1. Executive Summary
2. China Cancer Drugs Market
3. Market Share – China Anti-Cancer Drugs
4. Drugs – China Cancer Market
5. Cancer Type – Market
6. Therapy – China Cancer Market
7. Company Analysis
8. Growth Drivers
9. Challenges

Few Points from List of Figures Provided in China Cancer Drugs Market Report:

Figure 2‑1: China – Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 2‑2: China – Forecast for Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 3‑1: By Drugs – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3‑2: By Drugs – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3‑3: By Cancer – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3‑4: By Cancer – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 3‑5: By Therapy – China Anti-Cancer Drugs Market Share (%), 2011 – 2017
Figure 3‑6: By Therapy – Forecast for China Anti-Cancer Drugs Market Share (%), 2018 – 2024
Figure 4‑1: Cytotoxic Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4‑2: Cytotoxic Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4‑3: Antimetaboloties – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4‑4: Antimetaboloties – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4‑5: Plant Alkaloids – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4‑6: Plant Alkaloids – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4‑7: Alkylating Agents – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4‑8: Alkylating Agents – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024
Figure 4‑9: Targeted Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2017
Figure 4‑10: Targeted Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2018 – 2024

Browse All Latest Pharmaceuticals Market Research Reports at https://www.reportsnreports.com/market-research/pharmaceuticals/.

Contact Info:
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports
Phone: + 1 888 391 5441
Website: https://www.reportsnreports.com/contacts/discount.aspx?name=1606562

Release ID: 392996

CONTACT ISSUER
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports
SUBSCRIBE FOR MORE